Cardurion Pharmaceuticals is a startup based in the United States, 1 tracked investor.
Cardurion Pharmaceuticals is a startup based in the United States. Brouky records 1 investor associated with the company.
Cardurion Pharmaceuticals develops novel therapeutics targeting cardiovascular diseases by focusing on PDE9 and CaMKII inhibition to address heart failure and arrhythmias.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.